DRG – More than 50 Years of Innovative Diagnostics The DRG group is a leading manufacturer of ELISAs for clinical diagnostics and research with distributors in over 110 countries. DRG is also the manufacturer of the DRG:HYBRiD-XL®, a fully automated analyzer for immunoassays and clinical chemistry. Founded in 1970, DRG International, Inc. provides a complete range of products and services to the diagnostic and research communities. DRG Instruments GmbH, was founded in 1973 by DRG International, Inc. (NJ, USA) and is based in Marburg, Germany. In 2021 DRG International, Inc. was acquired by BioCheck Inc. (CA, USA). Together with the DRG group, BioCheck’s goal is to provide timely information so that treatment can be initiated earlier and efficacy analyzed sooner to better the long-term outcomes. DRG is an ISO 13485:2016 certified company and operates in compliance with FDA 21 CFR 820 Quality System Regulation.